vs

Side-by-side financial comparison of Invesco (IVZ) and Monster Beverage (MNST). Click either name above to swap in a different company.

Monster Beverage is the larger business by last-quarter revenue ($2.1B vs $1.7B, roughly 1.3× Invesco). Monster Beverage runs the higher net margin — 21.1% vs -58.9%, a 79.9% gap on every dollar of revenue. On growth, Monster Beverage posted the faster year-over-year revenue change (17.6% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $351.2M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 5.9%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Monster Beverage Corporation is an American beverage company that manufactures energy drinks including Monster Energy, Relentless, Reign and Burn. The company was originally founded as Hansen's in 1935 in Southern California, originally selling juice products. The company renamed itself as Monster Beverage in 2012.

IVZ vs MNST — Head-to-Head

Bigger by revenue
MNST
MNST
1.3× larger
MNST
$2.1B
$1.7B
IVZ
Growing faster (revenue YoY)
MNST
MNST
+11.4% gap
MNST
17.6%
6.2%
IVZ
Higher net margin
MNST
MNST
79.9% more per $
MNST
21.1%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$81.0M more FCF
IVZ
$432.2M
$351.2M
MNST
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
5.9%
MNST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVZ
IVZ
MNST
MNST
Revenue
$1.7B
$2.1B
Net Profit
$-995.9M
$449.2M
Gross Margin
55.5%
Operating Margin
-86.2%
25.5%
Net Margin
-58.9%
21.1%
Revenue YoY
6.2%
17.6%
Net Profit YoY
-575.8%
65.9%
EPS (diluted)
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
MNST
MNST
Q4 25
$1.7B
$2.1B
Q3 25
$1.6B
$2.2B
Q2 25
$1.5B
$2.1B
Q1 25
$1.5B
$1.9B
Q4 24
$1.6B
$1.8B
Q3 24
$1.5B
$1.9B
Q2 24
$1.5B
$1.9B
Q1 24
$1.5B
$1.9B
Net Profit
IVZ
IVZ
MNST
MNST
Q4 25
$-995.9M
$449.2M
Q3 25
$356.4M
$524.5M
Q2 25
$197.4M
$488.8M
Q1 25
$171.1M
$443.0M
Q4 24
$209.3M
$270.7M
Q3 24
$55.0M
$370.9M
Q2 24
$132.2M
$425.4M
Q1 24
$141.5M
$442.0M
Gross Margin
IVZ
IVZ
MNST
MNST
Q4 25
55.5%
Q3 25
55.7%
Q2 25
55.7%
Q1 25
56.5%
Q4 24
55.3%
Q3 24
53.2%
Q2 24
53.6%
Q1 24
54.1%
Operating Margin
IVZ
IVZ
MNST
MNST
Q4 25
-86.2%
25.5%
Q3 25
16.5%
30.7%
Q2 25
14.1%
29.9%
Q1 25
18.1%
30.7%
Q4 24
19.6%
21.0%
Q3 24
6.6%
25.5%
Q2 24
13.9%
27.7%
Q1 24
14.4%
28.5%
Net Margin
IVZ
IVZ
MNST
MNST
Q4 25
-58.9%
21.1%
Q3 25
21.7%
23.9%
Q2 25
13.0%
23.1%
Q1 25
11.2%
23.9%
Q4 24
13.1%
14.9%
Q3 24
3.6%
19.7%
Q2 24
8.9%
22.4%
Q1 24
9.6%
23.3%
EPS (diluted)
IVZ
IVZ
MNST
MNST
Q4 25
$-2.61
Q3 25
$0.66
Q2 25
$-0.03
Q1 25
$0.38
Q4 24
$0.46
Q3 24
$0.12
Q2 24
$0.29
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
MNST
MNST
Cash + ST InvestmentsLiquidity on hand
$1.0B
$2.8B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$12.2B
$8.3B
Total Assets
$27.1B
$10.0B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
MNST
MNST
Q4 25
$1.0B
$2.8B
Q3 25
$973.1M
$2.6B
Q2 25
$922.7M
$2.1B
Q1 25
$821.7M
$1.9B
Q4 24
$986.5M
$1.5B
Q3 24
$1.0B
$1.6B
Q2 24
$878.5M
$1.6B
Q1 24
$895.7M
$3.6B
Total Debt
IVZ
IVZ
MNST
MNST
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
$199.1M
Q4 24
$890.6M
$374.0M
Q3 24
$890.3M
$748.8M
Q2 24
$890.1M
$748.7M
Q1 24
$1.3B
Stockholders' Equity
IVZ
IVZ
MNST
MNST
Q4 25
$12.2B
$8.3B
Q3 25
$14.0B
$7.7B
Q2 25
$13.9B
$7.2B
Q1 25
$14.7B
$6.5B
Q4 24
$14.6B
$6.0B
Q3 24
$14.8B
$5.8B
Q2 24
$14.6B
$5.9B
Q1 24
$14.6B
$8.6B
Total Assets
IVZ
IVZ
MNST
MNST
Q4 25
$27.1B
$10.0B
Q3 25
$28.4B
$9.6B
Q2 25
$28.5B
$8.7B
Q1 25
$28.1B
$8.2B
Q4 24
$27.0B
$7.7B
Q3 24
$27.5B
$8.1B
Q2 24
$27.2B
$8.1B
Q1 24
$28.1B
$10.1B
Debt / Equity
IVZ
IVZ
MNST
MNST
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
0.03×
Q4 24
0.06×
0.06×
Q3 24
0.06×
0.13×
Q2 24
0.06×
0.13×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
MNST
MNST
Operating Cash FlowLast quarter
$455.8M
$379.4M
Free Cash FlowOCF − Capex
$432.2M
$351.2M
FCF MarginFCF / Revenue
25.5%
16.5%
Capex IntensityCapex / Revenue
1.4%
1.3%
Cash ConversionOCF / Net Profit
0.84×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$2.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
MNST
MNST
Q4 25
$455.8M
$379.4M
Q3 25
$606.2M
$745.1M
Q2 25
$547.9M
$466.0M
Q1 25
$-84.6M
$507.6M
Q4 24
$316.9M
$461.7M
Q3 24
$438.4M
$618.4M
Q2 24
$489.1M
$436.3M
Q1 24
$-54.4M
$412.1M
Free Cash Flow
IVZ
IVZ
MNST
MNST
Q4 25
$432.2M
$351.2M
Q3 25
$586.4M
$701.5M
Q2 25
$530.4M
$434.6M
Q1 25
$-108.0M
$478.5M
Q4 24
$309.9M
$370.4M
Q3 24
$410.0M
$571.4M
Q2 24
$462.4M
$376.5M
Q1 24
$-75.4M
$346.1M
FCF Margin
IVZ
IVZ
MNST
MNST
Q4 25
25.5%
16.5%
Q3 25
35.7%
31.9%
Q2 25
35.0%
20.6%
Q1 25
-7.1%
25.8%
Q4 24
19.5%
20.4%
Q3 24
27.1%
30.4%
Q2 24
31.2%
19.8%
Q1 24
-5.1%
18.2%
Capex Intensity
IVZ
IVZ
MNST
MNST
Q4 25
1.4%
1.3%
Q3 25
1.2%
2.0%
Q2 25
1.2%
1.5%
Q1 25
1.5%
1.6%
Q4 24
0.4%
5.0%
Q3 24
1.9%
2.5%
Q2 24
1.8%
3.1%
Q1 24
1.4%
3.5%
Cash Conversion
IVZ
IVZ
MNST
MNST
Q4 25
0.84×
Q3 25
1.70×
1.42×
Q2 25
2.78×
0.95×
Q1 25
-0.49×
1.15×
Q4 24
1.51×
1.71×
Q3 24
7.97×
1.67×
Q2 24
3.70×
1.03×
Q1 24
-0.38×
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

MNST
MNST

Monster Energy Drinks Segment$1.2B57%
Sales Revenue Product Line$905.5M42%
Strategic Brands Segment$50.3M2%
Alcohol Brands Segment$29.0M1%

Related Comparisons